Purine nucleotide biosynthesis in leukemic promyelocytes treated with retinoids.
Tsutani
H
H
First Department of Internal Medicine, Fukui Medical School, Japan.
Kagawa
D
D
Uchida
M
M
Yoshimura
T
T
Tanaka
T
T
Ueda
T
T
Nakamura
T
T
D000368:Aged; D001853:Bone Marrow / Q000473:pathology; D002250:Carbon Radioisotopes; D002454:Cell Differentiation / Q000187:drug effects; D002460:Cell Line; D004224:Diterpenes; D005260:Female; D005998:Glycine / Q000378:metabolism; D006412:Hematopoietic Stem Cells / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D019271:Hypoxanthine; D007042:Hypoxanthines / Q000378:metabolism; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy* / Q000473:pathology; D009000:Monocytes / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D010641:Phenotype; D011684:Purine Nucleosides / Q000096:biosynthesis*; D000084562:Retinyl Esters; D014407:Tumor Cells, Cultured; D014801:Vitamin A / Q000031:analogs & derivatives* / Q000627:therapeutic use
D002250:Carbon Radioisotopes; D004224:Diterpenes; D007042:Hypoxanthines; D011684:Purine Nucleosides; D000084562:Retinyl Esters; D014801:Vitamin A; C014794:retinol palmitate; D019271:Hypoxanthine; D005998:Glycine